12:00 AM
May 28, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Akrimax sales and marketing update

Akrimax launched Suprenza phentermine orally disintegrating tablets in the U.S. as a short-term adjunct to treat...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >